Literature DB >> 15775841

IBD and Pregnancy.

Audrey H Calderwood1, Sunanda V Kane.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15775841      PMCID： PMC1480542     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  48 in total

Review 1.  Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility.

Authors:  R Roubenoff; J Hoyt; M Petri; M C Hochberg; D B Hellmann
Journal:  Semin Arthritis Rheum       Date:  1988-11       Impact factor: 5.532

2.  Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy.

Authors:  M Wikland; I Jansson; M Asztély; I Palselius; G Svaninger; O Magnusson; L Hultén
Journal:  Int J Colorectal Dis       Date:  1990-02       Impact factor: 2.571

3.  The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis.

Authors:  R J Porter; G M Stirrat
Journal:  Br J Obstet Gynaecol       Date:  1986-11

Review 4.  The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks.

Authors:  R L Brent
Journal:  Semin Oncol       Date:  1989-10       Impact factor: 4.929

5.  6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity.

Authors:  D H Present; S J Meltzer; M P Krumholz; A Wolke; B I Korelitz
Journal:  Ann Intern Med       Date:  1989-10-15       Impact factor: 25.391

6.  Safety of azathioprine in pregnancy in inflammatory bowel disease.

Authors:  E M Alstead; J K Ritchie; J E Lennard-Jones; M J Farthing; M L Clark
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

7.  Reversible male infertility due to sulphasalazine: studies in man and rat.

Authors:  C O'Moráin; P Smethurst; C J Doré; A J Levi
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

8.  European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group.

Authors:  J F Mayberry; I T Weterman
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

9.  Pregnancy in ulcerative colitis.

Authors:  O H Nielsen; B Andreasson; S Bondesen; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1983-09       Impact factor: 2.423

10.  Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid.

Authors:  L Ambrosius Christensen; S N Rasmussen; S H Hansen; S Bondesen; E F Hvidberg
Journal:  Acta Obstet Gynecol Scand       Date:  1987       Impact factor: 3.636
View more
  6 in total

1.  Inflammatory bowel disease in pregnancy.

Authors:  Dawn B Beaulieu; Sunanda Kane
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 2.  IBD: reproductive health, pregnancy and lactation.

Authors:  Philip Hendy; Georgina Chadwick; Ailsa Hart
Journal:  Frontline Gastroenterol       Date:  2014-04-15

3.  Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review.

Authors:  Birgit Terjung; Renate Schmelz; Robert Ehehalt; Jochen Klaus; Jana Knop; Sabine Schwind; Thomas Wilke; Andreas Stallmach
Journal:  Therap Adv Gastroenterol       Date:  2020-10-16       Impact factor: 4.409

Review 4.  Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management.

Authors:  Pegah Hosseini-Carroll; Monica Mutyala; Abhishek Seth; Shaheen Nageeb; Demiana Soliman; Moheb Boktor; Ankur Sheth; Jonathon Chapman; James Morris; Paul Jordan; Kenneth Manas; Felix Becker; Jonathan Steven Alexander
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

Review 5.  Pregnancy and medications in inflammatory bowel disease.

Authors:  Rena H Cao; Michael C Grimm
Journal:  Obstet Med       Date:  2020-05-11

Review 6.  Insights into the treatment of inflammatory bowel disease in pregnancy.

Authors:  Sarah E Shannahan; Jonathan M Erlich; Mark A Peppercorn
Journal:  Therap Adv Gastroenterol       Date:  2019-05-27       Impact factor: 4.409
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.